E40: A Bestie gets COVID, Delta breakthrough,...

(0:00) Michael Kratsios joins the show! (01:56) Is this administration anti-science? The Nature poll, DEI grants, and $8B down the drain (8:16) Climate science cuts: RCP 8.5 gets pulled and the "climate emergency" narrative collapses (13:45) $47B at NIH, Eroom's Law, and golden t ...  Show more

(00:00) Besties are back! (00:13) Dario's two-part essay: regulatory capture, doomerism, and the data center backlash (10:25) FINRA for AI vs. MPAA for AI: SROs, thinking tokens, and the "DMV for AI" (30:12) Is an open source ban coming? Harnesses, FDI, jobs, and recursive self-i ...  Show more

Laura Forczyk, Space Analyst and Owner of Astralytical, NASA Subject Matter Expert for planetary science missions, and author of "Rise of the Space Age Millennials," talks about the Virgin Galactic space flight. David Kotok, Co-Founder and CIO of Cumberland Advisors, discusses th ...  Show more

Does Space represent a real economic opportunity or are expensive endeavors like SpaceX a form of billionaire hubris? Youngme Moon , Felix Oberholzer-Gee , and Mihir Desai discuss the Race for Space, before debating the viability of the electric scooter market in cities around th ...  Show more

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, explains why people who recovered from Covid appear to have a lower risk of contracting the delta variant than those who got the Pfizer shot. Matt Baker, Chief Strategy Officer at Dell, discusses earnings results a ...  Show more

Stories from this episode: Blaming protesters for COVID-19 spread ignores the bigger threats to health 5G coronavirus conspiracy theorists are endangering the workers who keep networks running Telehealth wasn’t designed for non-English speakers The pandemic has made it harder to ...  Show more